PubMed:10228011
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-11 | protein | denotes | HLA class I |
| T2 | 62-70 | DNA | denotes | cyclin E |
| T3 | 125-128 | protein | denotes | E2F |
| T4 | 252-267 | protein | denotes | HLA class I Ags |
| T5 | 347-368 | protein | denotes | HLA class I molecules |
| T6 | 401-419 | cell_type | denotes | aortic endothelial |
| T7 | 431-450 | cell_type | denotes | smooth muscle cells |
| T8 | 480-491 | protein | denotes | HLA class I |
| T9 | 569-579 | protein | denotes | Rb protein |
| T10 | 587-605 | cell_line | denotes | T cell line Jurkat |
| T11 | 617-647 | cell_type | denotes | human aortic endothelial cells |
| T12 | 649-660 | protein | denotes | HLA class I |
| T13 | 686-688 | protein | denotes | Rb |
| T14 | 722-738 | protein | denotes | neutralizing Abs |
| T15 | 742-772 | protein | denotes | basic fibroblast growth factor |
| T16 | 774-778 | protein | denotes | bFGF |
| T17 | 803-816 | protein | denotes | FGF receptors |
| T18 | 861-882 | protein | denotes | HLA class I molecules |
| T19 | 891-899 | DNA | denotes | cyclin E |
| T20 | 941-968 | cell_type | denotes | quiescent endothelial cells |
| T21 | 1014-1016 | protein | denotes | Rb |
| T22 | 1061-1093 | DNA | denotes | dominant-negative cdk2 construct |
| T23 | 1104-1115 | protein | denotes | HLA class I |
| T24 | 1141-1143 | protein | denotes | Rb |
| T25 | 1158-1200 | DNA | denotes | dominant-negative cdk4 and cdk6 constructs |
| T26 | 1254-1280 | protein | denotes | cyclin D-associated kinase |
| T27 | 1295-1306 | protein | denotes | HLA class I |
| T28 | 1333-1358 | protein | denotes | cyclin E-dependent kinase |
| T29 | 1377-1379 | protein | denotes | Rb |
| T30 | 1405-1408 | protein | denotes | E2F |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-138 | Sentence | denotes | HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity. |
| S2 | 139-251 | Sentence | denotes | Chronic rejection of transplanted organs is manifested as atherosclerosis of the blood vessels of the allograft. |
| S3 | 252-451 | Sentence | denotes | HLA class I Ags have been implicated to play a major role in this process, since signaling via HLA class I molecules can induce the proliferation of aortic endothelial as well as smooth muscle cells. |
| S4 | 452-648 | Sentence | denotes | In this study, we show that HLA class I-mediated induction of cell proliferation correlates with inactivation of the Rb protein in the T cell line Jurkat as well as human aortic endothelial cells. |
| S5 | 649-842 | Sentence | denotes | HLA class I-mediated inactivation of Rb can be inhibited specifically by neutralizing Abs to basic fibroblast growth factor (bFGF), suggesting a role for FGF receptors in the signaling process. |
| S6 | 843-1017 | Sentence | denotes | Signaling through HLA class I molecules induced cyclin E-associated kinase activity within 4 h in quiescent endothelial cells, and appeared to mediate the inactivation of Rb. |
| S7 | 1018-1215 | Sentence | denotes | A cdk2 inhibitor, Olomoucine, as well as a dominant-negative cdk2 construct prevented HLA class I-mediated inactivation of Rb; in contrast, dominant-negative cdk4 and cdk6 constructs had no effect. |
| S8 | 1216-1443 | Sentence | denotes | Furthermore, there was no increase in cyclin D-associated kinase activity upon HLA class I ligation, suggesting that cyclin E-dependent kinase activity mediates Rb inactivation, leading to E2F activation and cell proliferation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 34-52 | NP | denotes | cell proliferation |
| C1 | 0-52 | NP | denotes | HLA class I-mediated induction of cell proliferation |
| C3 | 333-368 | NP | denotes | signaling via HLA class I molecules |
| C5 | 514-532 | NP | denotes | cell proliferation |
| C4 | 480-532 | NP | denotes | HLA class I-mediated induction of cell proliferation |
| C6 | 565-579 | NP | denotes | the Rb protein |
| C8 | 686-688 | NP | denotes | Rb |
| C7 | 649-688 | NP | denotes | HLA class I-mediated inactivation of Rb |
| C9 | 843-882 | NP | denotes | Signaling through HLA class I molecules |
| C11 | 1014-1016 | NP | denotes | Rb |
| C10 | 994-1016 | NP | denotes | the inactivation of Rb |
| C12 | 1018-1034 | NP | denotes | A cdk2 inhibitor |
| C13 | 1036-1046 | NP | denotes | Olomoucine |
| C15 | 1141-1144 | NP | denotes | Rb; |
| C14 | 1104-1144 | NP | denotes | HLA class I-mediated inactivation of Rb; |
| C16 | 1377-1392 | NP | denotes | Rb inactivation |
| C17 | 1424-1442 | NP | denotes | cell proliferation |
| R1 | C5 | C2 | coref-ident | cell proliferation,cell proliferation |
| R2 | C4 | C1 | coref-ident | HLA class I-mediated induction of cell proliferation,HLA class I-mediated induction of cell proliferation |
| R3 | C8 | C6 | coref-ident | Rb,the Rb protein |
| R4 | C9 | C3 | coref-ident | Signaling through HLA class I molecules,signaling via HLA class I molecules |
| R5 | C11 | C8 | coref-ident | Rb,Rb |
| R6 | C13 | C12 | coref-appos | Olomoucine,A cdk2 inhibitor |
| R7 | C15 | C11 | coref-ident | Rb;,Rb |
| R8 | C14 | C7 | coref-ident | HLA class I-mediated inactivation of Rb;,HLA class I-mediated inactivation of Rb |
| R9 | C16 | C10 | coref-ident | Rb inactivation,the inactivation of Rb |
| R10 | C17 | C5 | coref-ident | cell proliferation,cell proliferation |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-11 | protein_family_or_group | denotes | HLA class I |
| T2 | 34-52 | other_name | denotes | cell proliferation |
| T3 | 62-70 | DNA_domain_or_region | denotes | cyclin E |
| T4 | 96-107 | other_name | denotes | Rb function |
| T5 | 125-128 | protein_molecule | denotes | E2F |
| T6 | 197-212 | other_name | denotes | atherosclerosis |
| T7 | 220-233 | body_part | denotes | blood vessels |
| T8 | 241-250 | other_name | denotes | allograft |
| T9 | 252-267 | protein_family_or_group | denotes | HLA class I Ags |
| T10 | 347-368 | protein_family_or_group | denotes | HLA class I molecules |
| T11 | 401-419 | cell_type | denotes | aortic endothelial |
| T12 | 431-450 | cell_type | denotes | smooth muscle cells |
| T13 | 480-491 | protein_family_or_group | denotes | HLA class I |
| T14 | 514-532 | other_name | denotes | cell proliferation |
| T15 | 569-579 | protein_molecule | denotes | Rb protein |
| T16 | 587-605 | cell_line | denotes | T cell line Jurkat |
| T17 | 617-647 | cell_type | denotes | human aortic endothelial cells |
| T18 | 649-660 | protein_family_or_group | denotes | HLA class I |
| T19 | 686-688 | protein_molecule | denotes | Rb |
| T20 | 722-738 | protein_family_or_group | denotes | neutralizing Abs |
| T21 | 742-772 | protein_molecule | denotes | basic fibroblast growth factor |
| T22 | 774-778 | protein_family_or_group | denotes | bFGF |
| T23 | 803-816 | protein_family_or_group | denotes | FGF receptors |
| T24 | 861-882 | protein_family_or_group | denotes | HLA class I molecules |
| T25 | 891-899 | DNA_domain_or_region | denotes | cyclin E |
| T26 | 941-968 | cell_type | denotes | quiescent endothelial cells |
| T27 | 1014-1016 | protein_molecule | denotes | Rb |
| T28 | 1020-1034 | other_organic_compound | denotes | cdk2 inhibitor |
| T29 | 1036-1046 | other_organic_compound | denotes | Olomoucine |
| T30 | 1061-1093 | DNA_molecule | denotes | dominant-negative cdk2 construct |
| T31 | 1104-1115 | protein_family_or_group | denotes | HLA class I |
| T32 | 1141-1143 | protein_molecule | denotes | Rb |
| T33 | 1254-1280 | protein_molecule | denotes | cyclin D-associated kinase |
| T34 | 1295-1306 | protein_family_or_group | denotes | HLA class I |
| T35 | 1333-1358 | protein_family_or_group | denotes | cyclin E-dependent kinase |
| T36 | 1377-1379 | protein_molecule | denotes | Rb |
| T37 | 1405-1408 | protein_molecule | denotes | E2F |
| T38 | 1424-1442 | other_name | denotes | cell proliferation |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 197-212 | HP_0002621 | denotes | atherosclerosis |